Hi Greenie, This ship that we are all in command of is a very special ship. Do you want to know why? Well, it is always afloat and never sinks. Even if you have some bad days, and I can certainly attest to that, then we also have those good days. So we seem to be sailing in the right direction.
My father once taught me that every day is a good day as long as none of our loved ones dies. I was in that plastic bubble when he came and sat right in front of it. I was kind of feeling really bad until he told me that. GOD rest his soul... 18's, Marty On Sat, Nov 15, 2014 at 7:20 AM, Myvety2k via CMLHope < cmlhope@googlegroups.com> wrote: > Well thank you Marcie, I have this idea, let's make Skip a Fleet > Admiral, I'm not sure but I think he as had CML the longest. Will make > Marty Admiral that's next in line and I'll be Captain Dave. When I first > started flying real planes my instructor used to call me Capt. Dave. So > when I started flying RC airplanes last year I crashed a lot so one of the > guy's would call me Danger Dave. Of course now I can fly as good as the > rest of the guys. But their used to be a lot of broken plane parts on the > field. > > greenie > > > In a message dated 11/14/2014 10:51:23 P.M. Eastern Standard Time, > cmlhope@googlegroups.com writes: > > Greenie, we are all so thrilled you are doing well. If Marty is our > captain, I think you must be his first officer! > > Marcie > > Sent from my iPad > > On Nov 14, 2014, at 9:38 PM, Myvety2k via CMLHope < > cmlhope@googlegroups.com> wrote: > > I would like to thank each and everyone of you for your warm hearted > replies. > > greenie > > In a message dated 11/14/2014 9:36:20 P.M. Eastern Standard Time, > cmlhope@googlegroups.com writes: > > Thank you Marty, I should have added that I went into remission within 6 > months after starting Gleevec. I was having to get blood work every 3 > months now I get blood work every 6 months. I've had 27 BMB's so I'm glad > they do it by testing your blood. We all have our good days and then their > are a few bad days to so like my late Aunt used to say just take one day at > a time. And that's what I do. Today was one of those bad days but > tomorrow I'm sure will be better it always is. Everyone please take care of > yourself's I'm so lucky my wife Grace who takes good care of me. > > greenie > > > In a message dated 11/14/2014 7:35:36 P.M. Eastern Standard Time, > wa2...@gmail.com writes: > > Greenie, > > Hey, what took you so long? I am thrilled to hear this wonderful news. You > are blessed. > > 18's, > > Marty > > On Fri, Nov 14, 2014 at 2:29 PM, icandoallttc via CMLHope < > cmlhope@googlegroups.com> wrote: > >> Yahoo Greenie >> So happy for you!! >> Blessing >> Jeanie >> >> Sent from my iPhone >> >> On Nov 11, 2014, at 4:05 PM, Myvety2k via CMLHope < >> cmlhope@googlegroups.com> wrote: >> >> I received my results back from my 6 month blood work today and I'm >> Negative on BCR-ABL. >> >> greenie >> >> In a message dated 11/11/2014 2:14:49 P.M. Eastern Standard Time, >> cmlhope@googlegroups.com writes: >> >> Happy Veterans Day to all >> JeanieđČđșđžđșđž >> >> Sent from my iPhone >> >> On Nov 11, 2014, at 1:56 PM, Myvety2k via CMLHope < >> cmlhope@googlegroups.com> wrote: >> >> Thank you Elizabeth, I served 6 years in the Navy. >> >> greenie >> >> In a message dated 11/11/2014 1:43:34 P.M. Eastern Standard Time, >> ksnwo...@prodigy.net writes: >> >> Thinking of you all. Nick is critically anemic due to Gleevec. Hope >> Richard H., Shannon, Bobbie Doyle, and all keep up your sharing of info. >> thanks so much Marty for the reports from the clinical trials to reduce or >> stop Gleevec. >> Thank you to all Veterans on this day. Elizabeth Woods >> >> >> On Tuesday, November 11, 2014 4:32 AM, "cmlhope@googlegroups.com" < >> cmlhope@googlegroups.com> wrote: >> >> >> cmlhope@googlegroups.com >> <https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!forum/cmlhope/topics> >> Google >> Groups >> <https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!overview> >> [image: >> https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!overview] >> <https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!overview> >> Topic digest >> View all topics >> <https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!forum/cmlhope/topics> >> >> - Glivec and studies of stopping the drug >> >> <https://us-mg205.mail.yahoo.com/neo/launch?.partner=sbc&.rand=8fv0d9j9nknkk#group_thread_0> >> - 1 Update >> - Digest for cmlhope@googlegroups.com - 6 updates in 2 topics >> >> <https://us-mg205.mail.yahoo.com/neo/launch?.partner=sbc&.rand=8fv0d9j9nknkk#group_thread_1> >> - 1 Update >> >> Glivec and studies of stopping the drug >> <http://groups.google.com/group/cmlhope/t/839da881a2e6e455?utm_source=digest&utm_medium=email> >> Richard H <rbhuffm...@gmail.com>: Nov 10 09:05PM -0800 >> >> Yes. This was the reason I stopped Gleevec. I was also had Iron Deficient >> Anemia. I had to infuse the iron to help try to recover my RBC count >> because was below 9. I was also still taking Gleevec while doing this. >> On Monday, November 10, 2014 12:56:18 AM UTC-6, Shannon L wrote: >> Back to top >> <https://us-mg205.mail.yahoo.com/neo/launch?.partner=sbc&.rand=8fv0d9j9nknkk#digest_top> >> Digest for cmlhope@googlegroups.com - 6 updates in 2 topics >> <http://groups.google.com/group/cmlhope/t/6cf9af24d4b963a7?utm_source=digest&utm_medium=email> >> "Sue" <hol...@iinet.net.au>: Nov 10 07:13PM +0800 >> >> Hi Shannon >> >> >> >> There is also the Destiny Trial in the UK which is reduction down to >> 200mg for 12 months and then stop (there has been no report until after Dec >> 2014) >> >> The next Trial is named Spirit3 to see if people are being over medicated >> >> >> >> The Australian Survey will have 600 participants >> >> >> >> Sue Hurt >> >> (Australian) >> >> >> >> From: cmlhope@googlegroups.com [mailto:cmlhope@googlegroups.com >> <cmlhope@googlegroups.com>] >> Sent: Monday, 10 November 2014 6:22 PM >> To: Digest recipients >> Subject: [CMLHope] Digest for cmlhope@googlegroups.com - 6 updates in 2 >> topics >> >> >> >> >> cmlhope@googlegroups.com >> >> < >> https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!overview> >> Google Groups >> >> < >> https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!overview> >> >> >> Topic digest >> View all topics >> >> * Glivec and studies of stopping the drug - 5 Updates >> >> * Glivec and studies of stopping the drug - 1 Update >> >> < >> http://groups.google.com/group/cmlhope/t/839da881a2e6e455?utm_source=digest&utm_medium=email> >> Glivec and studies of stopping the drug >> >> >> Shannon L <shannonl.cam...@gmail.com <mailto:shannonl.cam...@gmail.com >> <shannonl.cam...@gmail.com>> >: Nov 09 03:58AM -0800 >> >> Hi All My name is Shannon I live in Sydney Australia >> Its been awhile since I have posted. >> I was diagnosed 1998 and after a few years went onto sti571 (glivec) and >> achieved remission within 2 months and I have been it ever since about 14 >> yrs. >> They are inviting participants (in Australia) to take a survey of >> stopping >> glivec I image they will do a study of stopping the drug. >> My question is does everyone know of the study done in USA of the stats >> of >> stopping they have indicated in this survey info that the percentage of >> success is 30-40% to me that SEEMS LOW what do you think. >> I do have some problems but I am stable on glivec. >> I hope this emil finds everyone well >> Shannon >> >> >> Marty Gartenberg <wa2...@gmail.com <mailto:wa2...@gmail.com >> <wa2...@gmail.com>> >: Nov 09 07:46AM -0500 >> >> Hi Shannon, there is a study called the STIM that is going on in the UK >> and >> it talks about Imatinib being stopped. It is kind of lengthily however it >> does go into detail. >> Good luck to you, and I have always said there will be a cure for CML in >> our lifetimes. >> If you follow any of my posts I always end them with two numbers. They are >> 18 which is the symbol for life. >> 18's to you Shannon >> Marty >> PS Shannon I encourage you to post any time that you like. There will >> usually be someone that may be able to answer your questions. Besides that >> we are all here to learn from and help each other >> Can Imatinib Be Stopped? >> >> Goodwin, Peter >> Article Outline >> [image: Collapse Box]Author Information >> >> ASH Abstracts 186 and 187 >> >> SAN FRANCISCOâThe early promise of the tyrosine kinase inhibitor (TKI) >> imatinib for treating chronic myeloid leukemia (CML) has continued to be >> fulfilled following the release of seven-year follow-up data at the ASH >> Annual Meeting here from the International Randomized Study of Interferon >> versus STI 571 (imatinib) (IRIS) with 553 patients. >> >> With diminishing rates of progression each year beyond year three, the >> case >> for stopping imatinib altogether was also discussed at the meeting >> following release of results from two studies in which the drug was >> discontinued among patients who had achieved enduring complete molecular >> responses to it for more than two years. >> >> IRIS investigator Stephen G. O'Brien MD, PhD, Senior Lecturer in >> Experimental Hematology at Northern Institute for Cancer Research of >> University of Newcastle upon Tyne, UK, gave the latest IRIS results to a >> packed audience at the meeting, showing an event-free survival rate of >> 81%, >> freedom from progression to accelerated phase/blast crisis of 93%, and an >> estimated overall survival rate of 86%, from the standard dose of 400 mg >> imatinib daily. >> >> And in the presentation that followed, François-Xavier Mahon, MD, >> Professor >> at Victor SĂ©galen University in Bordeaux, France, released early data from >> the Stop Imatinib (STIM) study, noting that remissions continued in about >> half of the patients after investigational discontinuation of imatinib >> therapyâwith a non-significant trend showing that patients previously >> treated with interferon were more likely to be among those whose >> remissions >> persisted without drugs. >> >> Dr. O'Brien said that in IRIS the projected cytogenetic response rate to >> imatinib (by Kaplan Meyer analysis) was 82%, and that after seven years of >> follow-up 60% of patients were still on imatinib, with 57% of all patients >> still in complete cytogenetic response (CCR). >> >> The impression that CCR holds the key to a âcureâ of CML was strengthened >> by comments he made after his talk: >> >> âIt seems that if you maintain your CCR for, say, three years, the chance >> of regressing at that point is essentially zero. So, achieving a CCR is, I >> guess, what we call a âsafe havenâ for the majority of patients: If you've >> achieved that and sustained it for, say, three years, you're in pretty >> good >> shape and the chance of progressing is virtually nil,â he said. >> Back to Top >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx# >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx> >> > >> | Article Outline >> Diminishing Rates of Relapse >> >> These words reflect the diminishing rates of relapse observed in the IRIS >> study in successive years. Rates of progression to accelerate phase or >> blast crisis each year were low at all timesâwith rates rising in the >> first >> two years (1.5% in the first year; 2.8% in the second year) and then >> diminishing after that (1.6%, 0.9%, 0.5%, 0%, 0.4% in years 3, 4, 5, 6, >> and >> 7, respectively)âwith only a single patient having disease progression to >> accelerate phase or blast crisis between years six and seven. >> [image: Figure. FRANOIS-XAVI...] >> Figure. FRANOIS-XAVI... >> Image Tools >> >> The total annual event rates, including loss of molecular complete >> remission and death, were similarly low (3.3% and 7.5%) in years one and >> two, and diminished thereafter (4.8%, 1.7%, 0.8%, 0.3%, and 2.0% in years >> three through seven). >> >> These data only apply, of course, to the majority of patients who prove >> sensitive to imatinib, and Dr. O'Brien noted that many patients who are >> resistant or refractory to the TKI are now candidates for other drugs and >> in some cases, allogeneic transplantation. >> >> Dr. O'Brien summed up his feelings about the current state of the art >> concerning imatinib therapy for CML: âI think it's encouraging on two >> fronts. One is that there's nothing new in years six and seven to cause >> alarm in terms of safety events. And the second isâparticularly in >> patients >> who achieved a complete cytogenetic responseâI think we can be very >> reassured that the vast majorityâespecially if you have that CCR for three >> yearsâare doing extremely well, with very few of those progressing.â >> Back to Top >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx# >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx> >> > >> | Article Outline >> STIM Study >> >> Encouraging data on long-term remission of CML among patients treated with >> imatinib gave rise to the French initiative to conduct a pilot study with >> 15 patients looking at stopping imatinib, and following this the >> multicenter STIM study with 50 patients, which began in July 2007 but >> which >> has already yielded earlyâbut provocativeâevidence that remission from CML >> can continue even after imatinib is stopped. >> >> Dr. Mahon said that patients were recruited into these studies only if >> they >> had received imatinib for at least three years and achieved sustained >> complete molecular remission (CMR) for two years before experimentally >> stopping the drug. >> >> The definition of sustained CMR was strict: BCR-ABL/ABL had to be below a >> detection threshold corresponding to a 5-log reduction (undetectable >> signal >> using RQ-PCR) for at least two years. Molecular relapse was defined as >> RQ-PCR positivity detected in two successive assays, and patients who >> relapsed were then retreated with imatinib (successfully) at a dose of 400 >> mg daily. >> >> In the latest follow-up of the pilot study, Dr. Mahon said that seven out >> of 15 patients had relapse within six months and all were restored to CMR >> by re-treatment with imatinib. The remaining eight patients were still in >> CMR a median of 37 months after stopping the drug. >> >> All of the patients in the pilot study had been treated with interferon >> before receiving imatinib, most of them responding to it. This raised the >> suggestionâwhich Dr. Mahon discussed in his talk at the ASH meetingâthat >> interferon may have conferred a benefit among patients who were >> subsequently treated with imatinib. >> >> Half of the patients in the STIM study had been pretreated with >> interferon, >> and some provocativeâbut as yet not statistically significantâdata have >> emerged showing an advantage among those who had previously received >> interferon before going on to imatinib therapy. >> >> By July 2008, 10 of the 15 patients who were still in CMR had received >> prior interferon. The latest assessment from a slide Dr. Mahon presented >> showed that 27 out of 49 patients followed for more than six months had >> had >> disease relapse; 14 of these had received only imatinib and the remaining >> 13 had been previously treated with interferon, while only two of the >> seven >> patients in STIM who have so far continued in CMR for 14 months had been >> treated with imatinib alone. >> >> Dr. Mahon summed up his interim conclusions by stating that they have >> confirmed that CMR can be sustained after stopping imatinib, and that >> although there seems to be an [as yet statistically unconfirmed] advantage >> among the patients who received interferon, it is possible to stop the >> drug >> in patients with sustained CMR even among those treated with imatinib >> alone. >> >> He reported that the probability of survival without molecular relapse >> nine >> months after discontinuing imatinib was 46%, with the curve looking flat, >> so far, out to 15 months. Importantly, the STIM study found that all >> patients were sensitive after imatinib re-challenge. >> Back to Top >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx# >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx> >> > >> | Article Outline >> âRecurring Questionâ >> >> When Dr. O'Brien was asked for a comment on Dr. Mahon's conclusion from >> the >> initial pilot study and the early results from the STIM study, he said, >> âI'm fascinated by it. There's probably a bit of a cultural difference, I >> think, because most of my patients in the UKâwhen I suggest >> [stopping]âdon't want to hand their pills back, and want to carry on. >> [image: Figure. STEPHEN G. O...] >> Figure. STEPHEN G. O... >> Image Tools >> >> âI think that's driven by the fact that they are tolerating the drug well. >> There are no safety concerns emerging with the long-term follow-up. And >> it's obviously having good efficacy in them. But this is a recurring >> question that I think we'll see more and more ofâand the French study is >> very important.â >> Back to Top >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx# >> < >> http://journals.lww.com/oncology-times/Fulltext/2009/02101/Can_Imatinib_Be_Stopped_.1.aspx> >> > >> | Article Outline >> Low Toxicities >> >> In the UK, he noted, the preference for continuing imatinib could be >> explained by relatively low toxicities, which were not a significant >> barrier to its use, with neutropenia and thrombocytopenia being minor >> toxicities that are merely irritating over time. >> >> âGI toxicity like diarrhea, for example, and a feeling of fatigue and >> malaise, sometimes, and muscle cramps can be troublesome in some patients >> over the years. But they're usually minor toxicities which, after many >> years, become rather wearing, rather than major toxicities,â he said. >> >> The bottom line for clinicians treating their patients with CML, according >> to Dr. O'Brien's interpretation of his IRIS results, is that imatinib at >> 400 mg remains the current standard for first-line drug therapy, even >> though there are exciting data among patient cohorts treated with >> nilotinib >> and dasatinib first-line, with cytogenetic response rates in excess of >> 95%. >> >> âI thinkâfor the futureâwhere we're going is to do comparative Phase III >> studies with the tyrosine kinase inhibitors in newly diagnosed patients to >> see if we can improve on imatinib. Because although the imatinib data is >> reassuring, it's clear that at six or seven years, perhaps a third of >> patients are not continuing on imatinib,â he said. >> >> *Supported by funding from Genentech BioOncology and Biogen Idec.* >> >> © 2009 Lippincott Williams & Wilkins, Inc. >> >> >> >> Shannon L <shannonl.cam...@gmail.com <mailto:shannonl.cam...@gmail.com >> <shannonl.cam...@gmail.com>> >: Nov 09 03:52PM -0800 >> >> Hi Everyone >> Thankyou Marty for the research information it was very informative, so >> they are combining stopping with interferon unfortunately I can't >> tolerate >> it I remember the first time before glivec. >> I hope everyone is having a wonderful day. >> >> On Sunday, November 9, 2014 10:58:55 PM UTC+11, Shannon L wrote: >> >> >> Richard H <rbhuffm...@gmail.com <mailto:rbhuffm...@gmail.com >> <rbhuffm...@gmail.com>> >: Nov 09 09:33PM -0800 >> >> What a great record. You didn't indicate how much Gleevec you are taking. >> I have read that several CMLers are taking reduced amounts and reaming in >> remission. I have seen a post by a lady that said see was very petite and >> she was only taking 100mg instead of 400mg. >> I don't know the percentage or of a combined results From the different >> studies I read sometime ago I believe the range you have is consistent >> with >> what I have read. You can read my results below. My ONC told be I needed >> to end my almost 6 year vacation and I am trying to requalify for a lower >> copay for Bosutinib. I have tested and they found no mutation. I have >> studied the side effects and I will be meeting with a Nurse to go over >> the >> side effects. Due to my other problems I am concerned about all the >> interactions with those Meds. >> I hope this has helped you. >> >> Richard H. >> >> Dxd 2/2003 >> >> 400mg Gleevec 3/2003 >> >> Undetectable 11/03 >> >> RT-PCR negative 11/04 >> >> QT-PCR .003 11/05 >> >> RBC 8. >> >> Gleevec Vacation 11/06-6/07 >> >> Iron infusion 11/06 >> >> Transfusions 12/06-5/07 >> >> QT-PCR .007 >> >> Gleevec 1/08 -5/08 >> >> Procrit 8/08-11/08 >> >> Gleevec Vacation 7/08-Present >> >> QT-PCR .003 4/09 >> >> QT-PCR .0015 6/09 >> >> QT-PCR .0021 9/09 >> >> QT-PCR .0028 1/10 >> >> QT-PCR .001 4/10 >> >> QT-PCR .00468 10/10 >> >> QT-PCR 1.049% 2/11 >> >> QT-PCR .0612% 8/11 >> >> QT-PCR 2.616 % 2/12 >> >> QT-PCR 2.410% 8/12 >> >> RT-PCR 9.183% 4/13 >> >> RT-PCR 4.57% 6/13 >> >> RT-PCR 10.183% 10/13 >> >> RT-PCR 10.577% 2/14 >> >> RT-PCR 16.050% 5/14 >> >> On Sunday, November 9, 2014 5:58:55 AM UTC-6, Shannon L wrote: >> >> >> >> Shannon L <shannonl.cam...@gmail.com <mailto:shannonl.cam...@gmail.com >> <shannonl.cam...@gmail.com>> >: Nov 09 10:56PM -0800 >> >> Hi Richard H >> >> Yes Glivec 400 mg has been good to me I have been very stable on the >> drug, >> Wow 6 years off glivec thank you so much for sharing your results just a >> question in your first holiday off glivec you had an iron injection is >> this >> because of cml? I am contemplating a small break as my stomach problems >> seem to be increasing and are at times very debilitating. I know I have >> been on many meds prior to glivec (chemo twice, cytarabine, hydroxia, and >> interferon) and Im sure my body sometimes struggles with it all. >> >> On Sunday, November 9, 2014 10:58:55 PM UTC+11, Shannon L wrote: >> >> Back to top >> >> < >> http://groups.google.com/group/cmlhope/t/22ca310a00448c54?utm_source=digest&utm_medium=email> >> Glivec and studies of stopping the drug >> >> >> myvet...@aol.com <mailto:myvet...@aol.com <myvet...@aol.com>> : Nov 09 >> 07:32AM -0500 >> Back to top >> <https://us-mg205.mail.yahoo.com/neo/launch?.partner=sbc&.rand=8fv0d9j9nknkk#digest_top> >> You received this digest because you're subscribed to updates for this >> group. You can change your settings on the group membership page >> <https://groups.google.com/forum/?utm_source=digest&utm_medium=email/#!forum/cmlhope/join> >> . >> To unsubscribe from this group and stop receiving emails from it send an >> email to cmlhope+unsubscr...@googlegroups.com. >> >> >> -- >> -- >> [CMLHope] >> A support group of http://cmlhope.com >> ------------------------------------------------- >> >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To post to this group, send email to CMLHope@googlegroups.com >> To unsubscribe from this group, send email to >> cmlhope-unsubscr...@googlegroups.com >> For more options, visit this group at >> http://groups.google.com/group/CMLHope >> --- >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To unsubscribe from this group and stop receiving emails from it, send an >> email to cmlhope+unsubscr...@googlegroups.com. >> For more options, visit https://groups.google.com/d/optout. >> >> -- >> -- >> [CMLHope] >> A support group of http://cmlhope.com >> ------------------------------------------------- >> >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To post to this group, send email to CMLHope@googlegroups.com >> To unsubscribe from this group, send email to >> cmlhope-unsubscr...@googlegroups.com >> For more options, visit this group at >> http://groups.google.com/group/CMLHope >> --- >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To unsubscribe from this group and stop receiving emails from it, send an >> email to cmlhope+unsubscr...@googlegroups.com. >> For more options, visit https://groups.google.com/d/optout. >> >> -- >> -- >> [CMLHope] >> A support group of http://cmlhope.com >> ------------------------------------------------- >> >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To post to this group, send email to CMLHope@googlegroups.com >> To unsubscribe from this group, send email to >> cmlhope-unsubscr...@googlegroups.com >> For more options, visit this group at >> http://groups.google.com/group/CMLHope >> --- >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To unsubscribe from this group and stop receiving emails from it, send an >> email to cmlhope+unsubscr...@googlegroups.com. >> For more options, visit https://groups.google.com/d/optout. >> >> -- >> -- >> [CMLHope] >> A support group of http://cmlhope.com >> ------------------------------------------------- >> >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To post to this group, send email to CMLHope@googlegroups.com >> To unsubscribe from this group, send email to >> cmlhope-unsubscr...@googlegroups.com >> For more options, visit this group at >> http://groups.google.com/group/CMLHope >> --- >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To unsubscribe from this group and stop receiving emails from it, send an >> email to cmlhope+unsubscr...@googlegroups.com. >> For more options, visit https://groups.google.com/d/optout. >> >> -- >> -- >> [CMLHope] >> A support group of http://cmlhope.com >> ------------------------------------------------- >> >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To post to this group, send email to CMLHope@googlegroups.com >> To unsubscribe from this group, send email to >> cmlhope-unsubscr...@googlegroups.com >> For more options, visit this group at >> http://groups.google.com/group/CMLHope >> --- >> You received this message because you are subscribed to the Google Groups >> "CMLHope" group. >> To unsubscribe from this group and stop receiving emails from it, send an >> email to cmlhope+unsubscr...@googlegroups.com. >> For more options, visit https://groups.google.com/d/optout. >> > > -- > -- > [CMLHope] > A support group of http://cmlhope.com > ------------------------------------------------- > > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To post to this group, send email to CMLHope@googlegroups.com > To unsubscribe from this group, send email to > cmlhope-unsubscr...@googlegroups.com > For more options, visit this group at > http://groups.google.com/group/CMLHope > --- > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To unsubscribe from this group and stop receiving emails from it, send an > email to cmlhope+unsubscr...@googlegroups.com. > For more options, visit https://groups.google.com/d/optout. > > -- > -- > [CMLHope] > A support group of http://cmlhope.com > ------------------------------------------------- > > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To post to this group, send email to CMLHope@googlegroups.com > To unsubscribe from this group, send email to > cmlhope-unsubscr...@googlegroups.com > For more options, visit this group at > http://groups.google.com/group/CMLHope > --- > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To unsubscribe from this group and stop receiving emails from it, send an > email to cmlhope+unsubscr...@googlegroups.com. > For more options, visit https://groups.google.com/d/optout. > > -- > -- > [CMLHope] > A support group of http://cmlhope.com > ------------------------------------------------- > > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To post to this group, send email to CMLHope@googlegroups.com > To unsubscribe from this group, send email to > cmlhope-unsubscr...@googlegroups.com > For more options, visit this group at > http://groups.google.com/group/CMLHope > --- > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To unsubscribe from this group and stop receiving emails from it, send an > email to cmlhope+unsubscr...@googlegroups.com. > For more options, visit https://groups.google.com/d/optout. > > -- > -- > [CMLHope] > A support group of http://cmlhope.com > ------------------------------------------------- > > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To post to this group, send email to CMLHope@googlegroups.com > To unsubscribe from this group, send email to > cmlhope-unsubscr...@googlegroups.com > For more options, visit this group at > http://groups.google.com/group/CMLHope > --- > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To unsubscribe from this group and stop receiving emails from it, send an > email to cmlhope+unsubscr...@googlegroups.com. > For more options, visit https://groups.google.com/d/optout. > > -- > -- > [CMLHope] > A support group of http://cmlhope.com > ------------------------------------------------- > > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To post to this group, send email to CMLHope@googlegroups.com > To unsubscribe from this group, send email to > cmlhope-unsubscr...@googlegroups.com > For more options, visit this group at > http://groups.google.com/group/CMLHope > --- > You received this message because you are subscribed to the Google Groups > "CMLHope" group. > To unsubscribe from this group and stop receiving emails from it, send an > email to cmlhope+unsubscr...@googlegroups.com. > For more options, visit https://groups.google.com/d/optout. > -- -- [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to CMLHope@googlegroups.com To unsubscribe from this group, send email to cmlhope-unsubscr...@googlegroups.com For more options, visit this group at http://groups.google.com/group/CMLHope --- You received this message because you are subscribed to the Google Groups "CMLHope" group. To unsubscribe from this group and stop receiving emails from it, send an email to cmlhope+unsubscr...@googlegroups.com. For more options, visit https://groups.google.com/d/optout.
